Ocrevus Targets Pro-inflammatory T-cells, Not Just B-cells, in PPMS, Study Finds
News, Ocrevus
In addition to significantly reducing subsets of B-cells — its main immune cell target — Ocrevus (ocrelizumab) lessens pro-inflammatory immune T-cells in people with primary progressive multiple sclerosis (PPMS), a ... Read more